Loading

Journal of Pharmacology and Clinical Toxicology

Probabilistic Risk Assessment of Consumer Exposure to Reproductive and Developmental Toxicants

Research Article | Open Access | Volume 3 | Issue 3

  • 1. Department of Risk Assessment, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), France
+ Show More - Show Less
Corresponding Authors
François Pouzaud, Department of Risk Assessment, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 rue Pierre et Marie Curie - 94701 Maisons-Alfort Cedex, France, Tel:+33-1-56-29-56-45
Abstract

In 2009, the French Health Ministry requested the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) to assess the risks for consumers regarding exposure to suspected endocrine disruptors (EDs) and/or reproductive toxicants (R2s). For the purpose of the study consumer products containing the selected EDs were identified from a national sector survey among manufacturers and available bibliographic data. For each product, use patterns and exposure scenario were defined for workers and general populations including vulnerable population. A scientific review of the effects on reproduction (fertility/development) and endocrine-disrupting potential was conducted in order to select critical doses for these target populations. Toxicological reference doses (TRs) were calculated as the ratio between critical doses and uncertainty factors. Both direct consumer exposure to EDs in consumer products and indirect exposure by the intake of contaminated air and house dust were considered. For each scenario, uptake doses were modelled through a probabilistic approach based on a one-dimensional Monte Carlo simulation.
Finally, the statistical distributions of doses through direct and indirect exposure were compared to TRs to assess the risk. Probabilistic exposure assessment was preferred to the deterministic approach because it includes uncertainty and variability in some parameters and therefore allows a more realistic description of consumer exposure. It also provides the opportunity to assess the final consumer exposure uncertainty by sensitivity analysis.
The method described was applied tofiveR2s and/or EDs: n-hexane, toluene, cisCTAC, orthophenylphenol (OPP) and methyl-tert-butylether (MTBE).
Results showed that exposure situations posing a potential risk for embryonic or foetal development may exist, due to occupational or non-occupational exposure of pregnant women to certain consumer products containing toluene, n-hexane or cisCTAC. Situations at risk for reproduction have also been brought to light, although ANSES emphasizes that strong uncertainties exist with regard to the risk situation identified for MTBE.

Keywords

• Endocrine disruptors

• Reproduction

• Consumer products

• Probabilistic approach

• Risk assessment

Citation

Durand E, Leroux C, Perouel G, Beausolei C, Dubois C, et al. (2015) Probabilistic Risk Assessment of Consumer Exposure to Reproductive and Developmental Toxicants. J Pharmacol Clin Toxicol 3(3):1049.

INTRODUCTION

In the last few decades, various scientific studies have drawn attention to the possible effects of chemicals found in the environment on human health and more specifically on reproductive function. Endocrine disruptors (EDs) and reproductive toxicants can be used in a wide variety of products. Substances classified as CMR substances in group 1A and 1B under Commission regulation (EC) n°1272/2008 are banned for use in consumer products. Currently, there are no restrictions to the use of reproductive toxicants of group 2 (R2s) and/ or suspected EDs in consumer products, except as otherwise provided for in the Reach regulation or other sectoral regulations (e.g. Commission regulation (EC) no 790/2009 for cosmetics). Therefore the health risks for consumer exposed to EDs and/or R2s are of specific concern and should be assessed more precisely. In this context, the French Health Ministry requested ANSES in 2009 to identify and characterize potential exposure situations at risk to health and associated with usual consumer products and/or items containing certain chemicals classified as R2s or identified as being potential EDs by the European Commission.

Mixtures and articles containing R2s and/or EDs to be considered for health risk assessment (HRA) were prioritized after a French sector survey. Finally, five of the reproductive toxicants and/or suspected EDs contained in those consumer products available to the “general population” were selected.

The objective of this work is to apply the principles of HRA for the evaluation of n-hexane, toluene, cis-CTAC, OPP and MTBE, with particular emphasis on the description of exposure probabilistic assessment. The methodology and the conclusions of the five evaluations discussed in this work are published on ANSES website [1].

It should be noted that exposure through use of cosmetics, drugs or phytopharmaceutical products and the intake of contaminated food was not considered in the framework of ANSES expertise assessment.

METHODS

Consumer health risk regarding exposure to EDs/R2s was assessed according to the general 4-steps methodology developed by the NRC in 1983: 1) hazard identification, 2) dose-response assessment, 3) exposure assessment, and 4) risk characterization [2,3].

When dealing with reproductive toxicants, HRA specific adjustments were necessary to take into account certain key parameters such as the existence of vulnerable populations (pregnant women, children) in conjunction with windows of susceptibility related to the different phases of human life (in utero development for example) or delayed effects. Moreover, discontinuous exposure situations due to more or less use of consumer products required also specific considerations.

Hazard identification and dose-response assessment

An analysis of the available scientific studies published up to 2013 on the effects of these five substances was performed with a special emphasis on reproductive effects (i.e. fertility or developmental) [4-8]. This led to the identification of critical effects considered relevant to the HRA. Key studies and dose descriptors such as NOAELs and LOAELs to be used for the HRA were selected considering the quality of the data set (based on Klimischcriteria [9] and for assessment of study reliability and data extraction). The reliability and plausibility of the effects observed and their relevance to humans were also evaluated. In general, the OECD’s test guidelines and GLP studies were preferred but all relevant toxicological information, including non-standard academic research studies, were considered.

Subsequently, the target populations to be considered for the HRA (the general population and workers) were examined in relation to the periods of exposure in the key studies:

-the exposure of pregnant women was characterized to assess the risk to embryo-foetal development.

- adults or children exposure (male or female) was characterized to assess the risk to reproduction.

Finally, toxicological references doses1 (TRs) were calculated for each critical doses, taking into account uncertainty factors (UFs) (e.g. interspecies and intraspecies UFs). ANSES considered the default hypothesis that a threshold dose does exist for chemical substances causing an effect on reproduction and/ or development, except if data tend to show that there is no threshold [10].

The selection of TRs was based on a conservative approach, insofar as the critical dose ultimately selected was the value providing the greatest protection. Because of the lack of available studies, it was not always possible to derive a TR for each of the effects considered.

Exposure assessment

Both the general population and workers using consumer products were considered in the exposure assessments. Two complementary approaches were developed to characterize direct exposure from the use of products and indirect exposure from background concentrations in environmental media.

Direct exposure, caused by the use of the considered product, was assessed through a three steps approach involving 1) identification and selection of consumer products containing EDs/R2s, 2) selection of data to construct exposure scenario and assess consumer exposure, and 3) calculation of uptake doses. Furthermore, a sensitivity analysis was conducted to identify the most influential parameters on the doses calculated. Consumer products (mixtures and articles) containing R2s/EDs were identified from a national sector survey conducted between August 2010 and May 2011 among manufacturers. Additional information was gathered from the available bibliographic data and databases on consumer product composition registered between 2000 and 2012. Data on workers exposure were also identified in Colchicdatabase. Using this inventory, the products to be considered for risk assessment were selected, considering the likelihood of consumer exposure and data availability to quantify exposure (e.g. data on composition, recommendations for use, measured data, etc.). Exposure scenarios were developed for each product selected, taking into account the use patterns of products, frequency of use, target population (children, workers, general population), relevant routes of exposure (i.e. inhalation, dermal contact, ingestion) and physico-chemical properties of the substances. Subsequently, integrated exposure to EDs/R2s on the day of the event (i.e., the day the product was used) was modelled through a probabilistic approach by a one-dimensional Monte Carlo simulation in order to take into account the variability of input parameters of the scenarios (e.g. anthropometric data, housing characteristics, amount of the product, concentration of the compounds in the product). Probability distributions for each parameter were constructed from available data of all the relevant literature, with priority given to French data. Finally, a sensitivity analysis was conducted in order to determine the relative influence of each parameter on exposure and to have a better idea on the global level of confidence in the final results. This analysis also allowed highlighting gaps regarding the available information for influential parameters.


1 Toxicological reference dose is defined as the ratio between the critical dose (NOAEL or LOAEL) and uncertainty factors (UFs), when compared with exposure to reproductive toxicants, they can qualify or quantify a risk to human health. They are specific to a substance, duration of exposure (acute, intermediate or chronic), a route of exposure (inhalation, oral, dermal), a type of effect and a population (ANSES, 2007).

Indirect exposure through contact with media contaminated by multiple and/or undefined sources was assessed via a probabilistic approach using bibliographic data on EDs/R2s concentrations in air (indoor/outdoor) and house dust. French data were selected when available.

Uptake doses from direct and indirect exposure were calculated separately. Integrated doses (i.e. the sum of the corresponding doses for each route of exposure) were calculated when multiple routes of exposure were considered and converted into internal doses when appropriate. Aggregate exposure from concomitant use of consumer products was not specifically characterized in this study but was put into perspective with regard to HRA results.

Risk characterisation

The method developed for the HRA described below was identical for all five substances. The TRs calculated for each of the critical doses selected and each target population were compared with the probabilistic distributions of exposure doses for the HRA. When appropriate, TRs were converted into internal doses (iTRs) to take into account the toxicokinetic differences for the different routes of exposure.

Considering the windows of susceptibility of EDs, risk assessment for chemicals with intermittent exposure was discussed regarding the reversibility of effects, chemical toxicokinetics and frequency of exposure. For prenatal exposure, ANSES assumed that developmental toxicity could occur following a single exposure event.

Regarding other reproductive effects, risk assessment was considered relevant only if repeated uses lead to chronic exposure (e.g. if the product is used at least once a week). In this case, as for developmental effects, appropriate TRs were compared to probabilistic distributions of exposure doses to assess the risk.

According to the methodology developed by ANSES [3], the results of HRA for each substance and exposure scenario were considered as follows (Figure 1):

 Interpretation of results (exposure dose distribution and  toxicological reference dose) relating to a given chemical substance. TR: Toxicological reference doses. P95: The 95th percentile of the probabilistic distribution of exposure  doses.

Figure 1 Interpretation of results (exposure dose distribution and toxicological reference dose) relating to a given chemical substance. TR: Toxicological reference doses. P95: The 95th percentile of the probabilistic distribution of exposure doses.

Situation 1: The 95th percentile of the probabilistic distribution of exposure doses was above the TR: it was considered that risk situations could not be ruled out. A higher level of confidence was given for HRA results estimated from measured exposure situations, compared to those estimated from modelled exposure.

Situation 2: The 95th percentile of the probabilistic distribution of exposure doses was below the TR: risk was considered negligible. However, when the 95th of the exposure distribution exceeded 10% of the TR, the exposure associated with the use of the product was considered significant and was highlighted in the HRA results. For these products, it was estimated that concomitant exposure to the substance through other sources of exposure (e.g. use of several different products containing the substance on the same day) could lead to situation 1

RESULTS AND DISCUSSION

Hazard identification

The critical effects, TRs and iTRs considered for the HRAs are presented in (Table 1) [11-19].

Table 1: Key studies used for the HRA of five chemicals with developmental and reproductive toxicity effects.

Substance

Critical effects observed in animals

Key

study

Exposure

route

Starting point

/Uncertainty factors (UFs)

Toxicological reference dose (TR)

or internal TR (iTR)

General population

Occupational population

OPP (CAS n° 90-43-7)

Developmental effect (Increased incidence of litters with foetal resorption, without maternal toxicity)

[11]

oral

NOAEL 25 mg.kg-1bw.d-1

UFs=100

iTR=0.25

iTR=0.25

Toluene (CAS n° 108-88-3)

Developmental effect (Decrease in weight of offspring)

[12]

inhalation

NOAEC

1875 mg.m-3

UFs=100

TR*=4.7

TR*=14.1

n-hexane (CAS n°110-54-3)

Reprotoxicity effect (Decrease in testicular weight, atrophy of seminiferous tubules)

[13]

inhalation

LOAEC

3524 mg.m-3

UFs=300 or 150

TR*=9

TR*=74

Developmental effect (Increased number of foetal resorptions, and early and late resorptions)

[14]

inhalation

LOAEC

700 mg.m-3

UFs=300

TR*=2

TR*=6

cis-CTAC (CAS n° 51229-78-8)

Developmental effect (malformations (eye, facial and skeletal anomalies)).

[15]

oral

red

UFs=300

iTR=0.017

iTR=0.017

MTBE (CAS n°1634-04-4)

Reprotoxicity effect (Increase in the percentage of abnormal sperm, ↑ (40%) in the level of LH at D28)

[16]

oral

LOAEL

400 mg.kg-1bw.d-1

UFs=300 or 150

iTR=1.3

iTR=2.6

Change in levels of circulating hormones (↓ in level of testosterone, ↑ in level of corticosterone at D28)

[17]

oral

NOAEL

400 mg.kg-1bw.d-1

UFs=100 or 50

iTR=4

iTR=8

Developmental effect (Decrease in weight of newborns and delayed ossification)

[18]

 

inhalation

NOAEC

3600 mg.m-3

UFs= 100

TR*=9

TR*=27

Reprotoxicity effect (Decrease in survival index of newborns on PND4)

[19]

 

inhalation

LOAEC

900 mg.m-3

UFs= 300 or 150

TR*=0.53

TR*=4.5

This work was conducted using all the available publications on these substances, targeting data on the effects on reproductive function and on their modes of action that could involve an endocrine-disrupting mechanism of action. Regarding the substances classified as R2 (i.e., n-hexane, toluene and cis-CTAC), it should be noted that only few studies have been published since the earlier European assessments. Those ultimately selected were considered to be of sufficient quality to conduct the HRA. For all five substances, identification of reproductive hazards was based on animal studies since no reliable studies on humans were available. However, since there was no data indicating that these effects were specific to animals, it was assumed that they could be extrapolated to humans. Several reproductive effects were taken into account for n-hexane and MTBE. Only developmental effects were considered for toluene, cis-CTAC and OPP. The available studies for these substances were considered suitable for HRA, although some studies were outdated due to the few recent studies or non-standard academic research studies. However, regarding MTBE, uncertainties remain concerning the results of the Biles et al., (1987) [19] study, showing a nonmonotonic dose-response relationship, with an observable effect for the two lowest doses but no effect observed at the highest dose.

Moreover, critical non-reproductive toxicity effects occurring at the lowest dose (e.g. neurotoxicity for toluene and n-hexane) were also considered for HRA. These results are not discussed in this paper.

Exposure assessment

Identification of consumer’s products containing EDs or R2s was rather difficult given the lack of data on associated formulations. Therefore, the products selected for HRA were only those with sufficient data to quantify consumer exposure.

Regarding direct exposure assessment, measurements at workplaces from the Colchic database were used to assess worker exposure to EDs/R2s during painting (toluene) and professional use of adhesive (n-hexane, toluene). Measurements at petrol service stations were used to assess the exposure of workers and the general population to n-hexane, toluene and MTBE associated with petrol vapour emissions. Measured data on exposure to toluene, n-hexane, cis-CTAC and OPP in other products were not available. Results from mathematical models used to assess exposure to these mixtures were considered suitable for HRA.

Regarding indirect exposure assessment via the intake of contaminated environmental media and house dust, no French data were available for EDs/R2s, except for toluene.

The data used for direct and indirect exposure assessment are summarized in (Table 2) [20-27].

Table 2: Data on uses and environmental contamination for OPP, n-hexane, toluene, cis-CTAC and MTBE selected for the HRA.

  Direct Exposure assessment Indirect exposure assessment
Substance (General information) Method Products considered for HRA 95th of exposure on day of event (mg.m-3 OR mg.kg1.j-1) (general public) 95th of exposure on day of event (mg.m3 OR mg.kg-1.j-1) (workers) Method 95th of exposure
OPP (Use for its biocidal properties as a disinfectant and preservative). Routes of exposure: inhalation and dermal contact Modelling of exposure concentrations in air and quantities of OPP on the surface of the skin. Calculation of internal exposure doses (mg. kg-1.j-1) Insecticides 6,3.10^{-4}(PW) ; 5,3.10^{-4}(W) ; 
5,4.10^{-4}(M) 
NC Indoor and outdoor air Settled dust [20], [21]  
Household disinfectant
surface cleaners (liquid)
7,0.10^{-5}(PW) ; 7,2.10^{-5}(W) ; 6,3.10^{-5}(M) 7,6.10^{-3} (PW) ; 4,6.10^{-3} 
(W) ; 4,9.10^{-3} (M)
5,0.10^{-4} (PW) ; 5,5.10^{-4}(W) ; 4,5.10^{-4}(M)
Household disinfectant 
surface cleaners (wipes)
1,1.10^{-6}(PW) ; 1,2.10^{-6}(W) ; 2,0.10^{-6} (M) 6,9.10^{-5} (PW) ; 4,4.10-5 (W); 4,4.10^{-5} (M)
Household disinfectant 
surface cleaners (spray)
1,3.10^{-4}(PW); 1,4.10^{-4} (W); 1,2.10^{-4}(M) 1,1.10^{-1} (PW); 6,0.10^{-2} (W); 6,0.10^{-2} (M)
Bathroom cleaning products 1,4.10^{-4}(PW); 1,2.10^{-4} (W); 1,3.10^{-4}(M) NC
Room air fresheners 3,0.10^{-2}(PW) ; 2,0.10^{-2}(W) ; 2,2.10^{-2} (M) NC
Car air fresheners 9,7.10^{-4}(PW); 8,1.10^{-4} (W); 8,8.10^{-4}(M) 9,7.10^{-4} (PW); 8,1.10^{-4} (W); 8,8.10^{-4} (M)
Metal degreasing agents 8,0.10^{-2} (PW) ; 8,0.10^{-2}(W) ; 8,0.10^{-2} (M) NC
Toluene Use as a solvent or as an intermediate in chemical synthesis. -Route of exposure: inhalation
- Modelling of 
exposure concentrations in air 
(mg.m-3)
- Exposure 
measurement 
data (French 
data extracted 
from Colchic 
INRS 2013):
- Liquid paints, 
paint thinners 
and varnish: occupational population. 
- Liquid glues: 
occupational 
population
- Fuel: general 
and occupational 
population.
Adhesives (glues) 6,5 mg.m^{-3} (PW, W and M) 78 mg.m^{-3} ((PW, W and M) Indoor and outdoor air
[22]
French OQAI 
data, 2003-2005
0,07 mg.m^{-3} (PW, W and M)
Adhesives (spray) 8,5.10-3 mg.m^{-3} ((PW, W and M) NC
Paints (liquid) 7,7. mg.m^{-3} (PW, W and M) 52 mg.m^{-3} ((PW, W and M)
Paints (spray), 0,3 mg.m^{-3} (PW, W and M) 0,7 mg.m^{-3}(PW, W and M)
Paint thinners [10 – 96] mg.m^{-3}(PW, W and M) 52 mg.m^{-3} ((PW, W and M)
Paint (hobbies) 0,15 mg.m^{-3} (PW, W and M) NC
Wood varnish, 21 mg.m^{-3} (PW, W and M) 52 mg.m^{-3}((PW, W and M)
Paint strippers for wood 42 mg.m^{-3} (PW, W and M) 560 mg.m^{-3} (PW, W and M)
Wood maintenance products 8,8.10-4 mg.m^{-3} (PW, W and M) NC
Spray degreasing agents for metal 0,9 mg.m^{-3} (PW, W and M) 49 mg.m^{-3}(PW, W and M)
Spray for car plastic 6,2 mg.m^{-3} (PW, W and M) 329 mg.m^{-3} (PW, W and M)
Fuel 1,7.10-2 mg.m^{-3} (PW, W and M) 2,0 mg.m^{-3} (PW, W and M)
n-hexane Use as 
a solvent in consumer goods
  Adhesives (glue, spray), 
Adhesive thinners, Paints 
(liquid, spray), Metal Lubricant and Degreasing 
agents, Car air freshener 
(solid form and spray), 
Car plastic renovators, 
Stain remover liquid for 
textiles (liquid, spray), 
Textile waterproofing 
products, Waxes/varnishes, Insecticide, Fuel 
Route of exposure: inhalation
Modelling of exposure concentrations in air.
Exposure measurement data 
(French data extracted from 
Colchic INRS 2013):
- Liquid glues and glue thinners: occupational population
- Fuel: general and occupational populations. 
  General and occupational populations: paint 
strippers for 
wood, glues and 
glue thinners.
Sensitivity 
analysis (most 
sensitive parameter):
1/ mass concentration
2/ air exchange 
rate and duration of use
Indoor and 
outdoor air
[23]
(European 
data)
Sensitivity analysis 
(most sensitive parameter): concentration in 
indoor air
Cis-CTAC Use as 
a preservative in 
numerous products, and in certain repellents in 
particular.
  Textile treatment products (spray) (insect 
repellent and ironing 
spray), Textile treatment 
products (insect repellent), Repellents for skin 
application (gel, spray), 
Adhesives, Paints, Detergents, Waxes/varnishes
Route of exposure: dermal
Modelling of quantities of 
cis-CTAC on the surface of 
the skin.
Calculation of internal exposure doses 
  General population: repellents 
in gel for skin 
application.
Occupational 
population: liquid glues.
Sensitivity 
analysis (most 
sensitive parameter): 
1/ mass concentration
2/ frequency 
of use
No data identified
MTBE Use as an additive in petrol. Route of exposure: inhalation
Exposure measurement data 
(French data 
extracted from 
Colchic INRS 
2013):
- Fuel: general 
and occupational 
populations.
Fuel     Sensitivity 
analysis (most 
sensitive parameter): MTBE 
concentration in 
the petrol station air.
Indoor and 
outdoor air 
Finnish and 
Belgian data: 
[24-27]. 
Sensitivity analysis 
(most sensitive parameter): concentration in 
indoor air

Probabilistic distributions of exposure parameters and exposure doses are not presented in this paper..

Risk assessment

Ultimately, it was only possible to assess risks to adults (female or male) and to the unborn children of pregnant women, due to the lack of toxicological reference doses for the other populations or age groups of interest (young children, adolescents, etc.).

Exposure situations posing a potential reproductive risk for adults or a potential risk for embryonic or foetal development due to occupational or non-occupational exposure of pregnant women to certain products containing toluene, n-hexane or cis-CTAC are summarized in (Table 3).

Table 3: Summary of results of HRA associated to the use of products containing one of the following substances.

Products and uses   Substances Target population 95th percentile (mg/m3) or (mg/ kg/j) TRs Developmental toxicity TRs Reproductive toxicity RCRs Developmental toxicity RCRs Reproductive toxicity Risk of in utero developmental effects associated with the use of a product by pregnant women. Risk of a reproductive toxicity effects (other than an effect on foetal development) associated with the use of a product by adults.
  Liquid glues Toluene GP (PW) 6,5 mg.m^{-3} 4,7 mg.m^{-3} No data 1,4 Not concerned situations presumed at risk Not concerned
      OP (PW) 78 mg.m^{-3} 14,1 mg.m^{-3} No data 5,5 Not concerned situations at risk  
    n-hexane GP (PW) 51 mg.m^{-3} 2 mg.m^{-3} Not considered 26 0,23 situations presumed at risk Not considered
      OP (PW and M) 17,6 mg.m^{-3} 6 mg.m^{-3} 74mg.m^{-3} 2,9 Not concerned situations at risk situations with significant exposure
    cis-CTAC GP (PW) 1,1.10-2 mg.kg^{-1}j^{-1} 0,017 mg.kg^{-1}j^{-1} No data 0,65 Not concerned situations with significant expos Not concerned
      OP (PW) 1,1.10-2 mg.kg^{-1}j^{-1} 0,017 mg.kg^{-1}j^{-1} No data 0,65 Not concerned situations with significant expos Not concerned
  Liquid paints Toluene GP (PW) 7,7 mg.m^{-3} 4,7 mg.m^{-3} No data 1,6 Not concerned situations presumed at risk Not concerned
      OP (PW) 52 mg.m^{-3} 14,1 mg.m^{-3} No data 3,7 Not concerned situations at risk Not concerned
    n-hexane GP (PW) 9,8 mg.m^{-3} 2 mg.m-3 Not considered 4,9 Not concerned situations presumed at risk Not concerned
      OP (PW and M) 73 mg.m^{-3} 6 mg.m-3 74 mg.m^{-3} 12 0,99 situations presumed at risk situations with significant exposure for adult male
  Spray paints Toluene OP (PW) 1,7 mg.m^{-3} 14,1 mg.m-3 No data 0,12 Not concerne situations with significant exposure Not concerned
    n-hexane OP (PW and M) 19 mg.m^{-3} 6 mg.m^{-3} 74 mg.m^{-3} 3,2 0,26 situations presumed at risk situations with significant exposure for adult male
  Varnishes Toluene GP (PW) 21 mg.m^{-3} 4,7 mg.m^{-3} No data 4,5 Not concerned situations presumed at risk Not concerned
      OP (PW) 52 mg.m^{-3} 14,1 mg.m^{-3} No data 3,7 Not concerned situations at risk Not concerned
    cis-CTAC GP (PW) 5,3.10-3
mg.kg^{-1}j^{-1}
0,017
mg.kg^{-1}j^{-1}
No data 0,31 Not concerned significant exposure situations Not concerned
HOMEIMPROVEMENT PRODUCTS     OP (PW) 5,3.10-3 mg.kg^{-1}j^{-1} 0,017 mg.kg^{-1}j^{-1} No data 0,3 Not concerned significant exposure situations Not concerned
  Paint strippers for wood Toluene GP (PW) 42 mg.m^{-3} 4,7 mg.m^{-3} No data 8,9 Not concerned situations presumed at risk Not concerned
      OP (PW) 560 mg.m^{-3} 14,1 mg.m^{-3} No data 40 Not concerned situations presumed at risk Not concerned
    n-hexane GP (PW) 30 mg.m^{-3} 2 mg.m^{-3} Not considered 15 Not concerned situations presumed at risk Not concerned
      OP (PW and M) 295 mg.m^{-3} 6 mg.m^{-3} 74 mg.m^{-3} 49 4,0 situations presumed at risk situations presumed at risk
  Liquid degreasing agents/ lubricants for metal n-hexane GP (PW) 20 mg.m^{-3} 2 mg.m^{-3} Not considered 10 Not considered situations presumed at risk Not considered
    OPP OP (PW) 8,0.10-2 mg.kg^{-1}j^{-1} 0,25 mg.kg^{-1}j^{-1} No data 0,32 Not concerned situations with significant exposure Not concerned
  Spray degreasing agents/ lubricants for metal n-hexane GP (PW) 0,26 mg.m^{-3} 2 mg.m^{-3} Not considered 0,13 Not considered situations with significant exposure Not considered
      OP (PW and M) 23 mg.m^{-3} 6 mg.m^{-3} 74 mg.m^{-3} 4,3 0,31 situations presumed at risk situations with significant exposure
    Toluene GP (PW) 0,9 mg.m^{-3} 4,7 mg.m-3 No data 0,19 Not concerned Situations with significant exposure Not concerned
      OP (PW) 49 mg.m^{-3} 14,1 mg.m^{-3} No data 3,5 Not concerned situations presumed at risk Not concerned
  Paint thinners Toluene GP (PW) 10 mg.m^{-3} 4,7 mg.m^{-3} No data 2,1 Not concerned situations presumed at risk Not concerned
      OP (PW) 52 mg.m^{-3} 14,1 mg.m^{-3} No data 3,7 Not concerned situations at risk Not concerned
  Glue thinners n-hexane GP (PW) 41 mg.m^{-3} 2 mg.m^{-3} Not considered 21 Not concerned situations presumed at risk ituations with significant exposure
      OP (PW and M) 17,6 mg.m^{-3} 6 mg.m^{-3} 74 mg.m^{-3} 2,9 0,24 situations at risk Not concerned
  Plastic renovators Toluene GP (PW) 6,2 mg.m^{-3} 4,7 mg.m^{-3} No data 1,3 Not concerned situations presumed at risk Not concerned
      OP (PW) 329 mg.m^{-3} 14,1 mg.m^{-3} No data 23 Not concerned situations presumed at risk Not concerned
    n-hexane GP (PW) 0,28 mg.m^{-3} 2 mg.m^{-3} Not considered 0,14 Not considered situations with significant exposure Not considered
      OP (PW and M) 3,1 mg.m^{-3} 6 mg.m^{-3} 74mg.m^{-3} 0,52 0,08 situations with significant exposure Not concerned*
  Car air freshener spray n-hexane GP (PW) 0,3 mg.m^{-3} 2 mg.m^{-3} Not considered 0,15 Not Concerned situations with significant exposure Not considered
      OP (PW) 0,3 mg.m^{-3} 2 mg.m^{-3}* Not concerned 0,15 Not Concerned situations with significant exposure Not concerned*
CLEANING & MAINTENANCE PRODUCTS Stain removers for textiles (liquid) n-hexane GP (PW) 2,4 mg.m^{-3} 2 mg.m^{-3} 9 mg.m^{-3} 1,2 0,27 situations presumed at risk situations with significant exposure
      OP (PW 
and M)
61 mg.m^{-3} 6 mg.m^{-3} 74 mg.m^{-3} 10 0,82 situations presumed at risk situations with significant exposure for adult male
  Textile waterproof-ing products (spray) n-hexane GP (PW) 2,4 mg.m^{-3} 2 mg.m^{-3} Not concerned 1,2 Not considered situations presumed at risk Not considered
      OP (PW and M) 95 mg.m^{-3} 6 mg.m^{-3} 74 mg.m^{-3} 15,8 1,3 situations presumed at risk situations with significant exposure for adult male
  Textile treatment products (liquid) cis-CTAC GP (PW) 5,9.10-3 mg.kg^{-1}j^{-1} 0,017 mg.kg^{-1}j^{-1} No data 0,35 Not concerned Situations with significant exposure Not concerned
  Detergents, household cleaners (liquid) cis-CTAC OP (PW) 3,4.10-3 mg.kg^{-1}j^{-1} 0,017 mg.kg^{-1}j^{-1} No data 0,2 Not concerned Situations with significant exposure Not concerned
  Detergents, household cleaners (spray) OPP OP (PW) 1,1.10-1 mg.kg^{-1}j^{-1} 0,25 mg.kg^{-1}j^{-1} No data 0,44 Not concerned Situations with significant exposure Not concerned
  Wood maintenance products (waxes, floor polishes) (spray) n-hexane GP (PW) 0,23 mg.m^{-3} 2 mg.m^{-3} Not considered 0,12 Not considered Situations with significant exposure Not considered
      OP (PW and M) 11 mg.m^{-3} 6 mg.m^{-3} 74 mg.m^{-3} 1,8 0,15 situations presumed at risk situations with significant exposure
  Fuel - exposure in service stations MTBE OP (PW and adults) 11 mg.m^{-3} 27 mg.m^{-3} 4,5 mg.m^{-3} 0,41 2,4 situations with significant exposur situations at risk for adults
FUEL   n-hexane OP (PW) 1,4 mg.m^{-3} 6 mg.m^{-3} Not concerned 0,23 0,019 situations with significant exposure Not concerned*
    Toluene OP (PW) 2,0mg.m^{-3} 14,1mg.m^{-3} No data 0,14 Not concerned situations with significant exposure Not concerned
REPELLENTS Repellents for skin application (liquid/gel) cis-CTAC GP (PW) 2,2.10-2 mg.kg^{-1}j^{-1} 0,017 mg.kg^{-1}j^{-1} No data 1,3 Not concerned situations presumed at risk Not concerned
  Repellents for skin application (spray) cis-CTAC GP (PW) 7,6.10-3 mg.kg^{-1}j^{-1} 0,017 mg.kg^{-1}j^{-1} No data 0,45 Not concerned Situations with significant exposure Not concerned

Significant exposure situations (i.e., those exceeding 10 % of the TR) are also highlighted in (Table 3).

Regarding HRA results, the study was only able to identify a limited amount of information on consumer products containing EDs/R2s and associated formulation. Because of this, the data used for HRA are neither representative of the French market nor exhaustive with regard to all the products containing EDs/ R2s, especially for substances used as preservatives in a large number of mixtures. Since these data are essential in order to characterize population exposure and the possible risks to health, an update to the inventory of consumer products available on the French market and their associated formulations is needed to complete this work. However, in spite of these limits, experimental data were judged sufficiently robust to conduct the HRA. ANSES considers that exposure situations posing a potential risk for embryonic or foetal development may exist, due to occupational or non-occupational exposure of pregnant women to certain products (Home-improvement products, cleaning and maintenance products, repellents) containing toluene (Liquid glues, liquid paints, spray paints, varnishes, paint strippers for wood, spray degreasing agents/lubricants for metal, paints thinners, plastic renovators), n-hexane (Liquid glues, liquid paints, spray paints, paint strippers for wood, liquid degreasing agents/lubricants for metal, spray degreasing agents/lubricants for metal, glue thinners, plastic renovators, car air freshener sprays, stain removers for textile (liquid), textile waterproofing products spray), wood maintenance products (waxes, floor polishes) (spray), or cis-CTAC (Liquid glues, repellents for skin application (liquid/gel). The results of the HRA showed also that exposure in adults (men and women) when dispensing fuel or filling tanks (from a petrol tanker) could lead to situations likely to cause effects on reproduction in the exposed individuals.

No risk regarding other consumer products or indirect exposure via environmental media or the intake of contaminated house dust was expected.

CONCLUSION

Exposure resulting from the use of consumer products varies greatly from one individual to another due to the many possible conditions of use of these products, differences in product composition and inters individual physiological variation parameters. In this context, the HRA method developed by ANSES (available on ANSES website [3] based on probabilistic exposure assessment is eminently suitable as it covers as many exposure situations as possible. Moreover, the review and the use of several mathematical models and probabilistic distribution for associated parameters are of particular interest, because representative exposure data are generally not available.

Several recommendations were proposed for the five substances for which some situations of concerns were identified, such as informing consumers of the presence of these substances in products, avoiding the use of products listed in (Table 3) by pregnant women, and providing information on hygiene measures and good practices to limit exposure. ANSES also issues specific recommendations for each substance, in order to increase knowledge on the hazard of these substances and their mode of action, on the identification of safe substitutes, and on the conditions of population exposure. Cumulative and aggregate exposure to several consumer products containing EDs/R2s is of primary interest for ANSES and will be further addressed.

ACKNOWLEDGEMENTS

The authors would like to thank the ANSES working group on endocrine disruptors for their expert judgment and scientific assistance in this work. We are also indebted to INRS for the access to Colchic data. We are grateful to Dana Pottratz for the English checking.

Conflict of Interest

The authors take full responsibility for the drafting and content of this paper and have no competing interests to declare. Their affiliations are shown on the cover page.

REFERENCES

1. ANSES (French Agency for Food, Environmental and Occupational Health & Safety) Report on the assessment method for health risks linked to the presence of reproductive toxicants and/or endocrine disruptors in consumer products (report in French, 2014a).

2. Moore JA. Problems facing the decision-maker in the risk assessment process. Teratog Carcinog Mutagen. 1987; 7: 205-209.

3. NRC (National Research Council). Science and Decisions: Advancing Risk Assessment. Washington, DC: The National Academies Press. 2009.

4. ANSES (French Agency for Food, Environmental and Occupational Health & Safety), Opinion of the French Agency for Food, Environmental and Occupational Health & Safety on the assessment of the health risks associated with the presence of o-phenylphenol (OPP), toluene, n-hexane, cis-1(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC) and methyl tert-butyl ether (MTBE) in consumer products. Toluene (N° CAS 108-88-3)-Annexe 2: Toxicological report. (report in French, 2014b).

5. ANSES (French Agency for Food, Environmental and Occupational Health & Safety), Opinion of the French Agency for Food, Environmental and Occupational Health & Safety on the assessment of the health risks associated with the presence of o-phenylphenol (OPP), toluene, n-hexane, cis-1(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC) and methyl tert-butyl ether (MTBE) in consumer products. N-hexane (N° CAS 110-54-3)-Annexe 2: Toxicological report.(report in French, 2014c).

6. ANSES (French Agency for Food, Environmental and Occupational Health & Safety), Opinion of the French Agency for Food, Environmental and Occupational Health & Safety on the assessment of the health risks associated with the presence of o-phenylphenol (OPP), toluene, n-hexane, cis-1(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC) and methyl tert-butyl ether (MTBE) in consumer products. o-phenylpenol (N° CAS 90-43-7)-Annexe 2: Toxicological report.(report in French, 2014d).

7. ANSES (French Agency for Food, Environmental and Occupational Health & Safety), Opinion of the French Agency for Food, Environmental and Occupational Health & Safety on the assessment of the health risks associated with the presence of o-phenylphenol (OPP), toluene, n-hexane, cis-1(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC) and methyl tert-butyl ether (MTBE) in consumer products. Cis-CTAC (N° CAS 51229-78-8)-Annexe 2: Toxicological report.(report in French, 2014e).

8. ANSES (French Agency for Food, Environmental and Occupational Health & Safety), Opinion of the French Agency for Food, Environmental and Occupational Health & Safety on the assessment of the health risks associated with the presence of o-phenylphenol (OPP), toluene, n-hexane, cis-1(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC) and methyl tert-butyl ether (MTBE) in consumer products. MTBE (N° CAS 1634-04-4)-Annexe 2: Toxicological report. (report in French, 2014f).

9. Klimisch HJ, Andreae M, Tillmann U. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol. 1997; 25: 1-5.

10. ANSES(French Agency for Food, Environmental and Occupational Health & Safety), Toxicity reference values for reprotoxic substances. Method of establishing TRVs based on effects that are toxic to reproduction and development (report, 2007).

11. INRS (National research and safety institute). Colchic occupational exposure databank consultation, 2013.

12. Zablotny CL, Breslin WJ, Kociba RJ. Developmental toxicity of orthophenylphenol (OPP) in New Zealand White rabbits. 1991: Unpublished report.

13. Roberts LG, Bevans AC, Schreiner CA. Developmental and reproductive toxicity evaluation of toluene vapor in the rat - Reproductive toxicity Reproductive Toxicology. 2003; 17:649–658.

14. Nylén P, Ebendal T, Eriksdotter-Nilsson M, Hansson T, Henschen A, et al. Testicular atrophy and loss of nerve growth factor-immunoreactive germ cell line in rats exposed to n-hexane and a protective effect of simultaneous exposure to toluene or xylene. Arch Toxicol. 1989; 63: 296-307.

15. Mast T, Hackett P, Decker J, et.al. Inhalation reproductive toxicology studies: sperm morphology study of n-hexane in B6C3F1 mice. Prepared by the Pacific Northwest Laboratory Richland, WA, for the National Toxicology Program, National Institute for Environmental Health Services, Research Triangle Park, NC; PNL-6672.1988.

16. John JA, Ouellette JH, Quast JF. Dowicil 200: Oral Teratology Study in Fischer 344 Rats. The Dow Chemical Company, 1982. Report No: K-27342-47.

17. Li D, Yuan C, Gong Y, Huang Y, Han X. The effects of methyl tert-butyl ether (MTBE) on the male rat reproductive system. Food Chem Toxicol. 2008; 46: 2402-2408.

18. de Peyster A, MacLean KJ, Stephens BA, Ahern LD, Westover CM, Rozenshteyn D. Subchronic studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer. Toxicological Sciences.2003; 72: 31-42.

19. Bevan C, Tyl RW, Neeper-Bradley TL, Fisher LC, Panson RD, Douglas JF, et al. Developmental toxicity evaluation of methyl tertiary-butyl ether (MTBE) by inhalation in mice and rabbits. J Appl Toxicol. 1997; 17 Suppl 1: S21-29.

20. Biles RW, Schroeder RE, Holdsworth CE. Methyl tertiary butyl ether inhalation in rats: a single generation reproduction study. Toxicol Ind Health. 1987; 3: 519-534.

21. Rudel RA, Camann DE, Spengler JD, Korn LR, Brody JG. Phthalates, alkylphenols, pesticides, polybrominateddiphenyl ethers, and other endocrine-disrupting compounds in indoor air and dust. Environmental Science and Technology. 2003; 37: 4543-4553.

22. Rudel RA, Dodson RE, Perovich LJ, Morello - Frosch R, Camann DE, Zuniga MM, et al. Semivolatile endocrine-disrupting compounds in paired indoor and outdoor air in two northern california communities. Environmental Science and Technology. 2010; 44: 6583-6590.

23. Kirchner S, Cochet C, Derbez M, Duboudin C, Elias P, Gregoire A, et. al. État de la qualité de l’air dans les logements français Indoor air quality in French housing. Environnement, Risques & Société. 2007; 6: 259- 269.

24. Geiss O, Giannopoulos G, Tirendi S, Barrero-Moreno J, Larsen B, Kotzias D. The AIRMEX study - VOC measurements in public buildings and schools/kindergartens in eleven European cities: Statistical analysis of the data. Atmospheric Environment.2011; Vol. 42: 3676-3684.

25. Brits E, Goelen E, Koppen G, Spruyt M, Torfs R. The influence of Contaminants in Ambient Air on the Indoor Air Quality - Part 1: Exposure of children - Report of Work Package 1: Outline of the study. 67. 2005.

26. De Brouwere K, Cornelis C, Goelen E, Koppen G, Spruyt M, Torfs R. The influence of contaminants in ambient air on the indoor air quality - Part 1: exposure of children - Report of work package 3: interpretation and policy recommendations. 69. 2007.

27. Hellén H, Hakola H, Laurila T, Hiltunen V, Koskentalo T. Aromatic hydrocarbon and methyl tert-butyl ether measurements in ambient air of Helsinki (Finland) using diffusive samplers. Sci Total Environ. 2002; 298: 55-64.

28. Spruyt M, Bormans R, Desmet L, Geyskens F, Poelmans B, Van Hasselt B, et. al. The influence of contaminants in ambient air on the indoor air quality - Part 1: Exposure of children - Report of work Package 2: Fieldwork and measurements. 2006.

Durand E, Leroux C, Perouel G, Beausolei C, Dubois C, et al. (2015) Probabilistic Risk Assessment of Consumer Exposure to Reproductive and Developmental Toxicants. J Pharmacol Clin Toxicol 3(3):1049.

Received : 24 Jan 2015
Accepted : 10 Mar 2015
Published : 12 Mar 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X